gemcitabine 2 GM per 52.6 ML Injection
- RxCUI
- 1720975
- RxNorm name
- gemcitabine 2 GM per 52.6 ML Injection
- Display name
- gemcitabine 2 GM per 52.6 ML Injection
- Full name
- gemcitabine 2 GM per 52.6 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gemcitabine | GEMCITABINE | Hospira, Inc. | dc02a23b-3ff9-4441-aa91-8e9e629a7315 | 2026-04-27 | Warnings, Adverse reactions | 1720975 |
| Gemcitabine | GEMCITABINE | Hospira, Inc. | e18ed1cb-7dd0-4001-bfda-17d1f4587fb8 | 2026-04-27 | Warnings, Adverse reactions | 1720975 |
| Gemcitabine | GEMCITABINE | Hikma Pharmaceuticals USA Inc. | d80176fe-3e8b-48be-87c2-9c603013b3fa | 2025-10-24 | Warnings, Adverse reactions | 1720975 |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | c0b1b715-9ff8-43ca-9e49-465f1f380084 | 2025-07-23 | Warnings, Adverse reactions | 1720975 |
| Gemcitabine | GEMCITABINE | Sagent Pharmaceuticals | 22af3507-4b4f-4cad-9d61-89ffc4aabbc7 | 2025-02-03 | Warnings, Adverse reactions | 1720975 |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Mylan Institutional LLC | 06dd9d40-74fc-4409-93b1-a46be7126331 | 2024-11-11 | Warnings, Adverse reactions | 1720975 |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | 73ae04d8-38f9-4d3d-b0c2-71d22af1fc86 | 2024-08-05 | Warnings, Adverse reactions | 1720975 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| dc02a23b-3ff9-4441-aa91-8e9e629a7315 | 52.6 ML gemcitabine 38 MG/ML Injection | SCD | 28 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20260427 |
| dc02a23b-3ff9-4441-aa91-8e9e629a7315 | gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection | SY | 28 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20260427 |
| dc02a23b-3ff9-4441-aa91-8e9e629a7315 | gemcitabine 2 GM per 52.6 ML Injection | SY | 28 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20260427 |
| dc02a23b-3ff9-4441-aa91-8e9e629a7315 | gemcitabine 2 GM in 52.6 ML Injection | PSN | 28 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20260427 |
| 22af3507-4b4f-4cad-9d61-89ffc4aabbc7 | gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection | SY | 8 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20250203 |
| 22af3507-4b4f-4cad-9d61-89ffc4aabbc7 | 52.6 ML gemcitabine 38 MG/ML Injection | SCD | 8 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20250203 |
| 22af3507-4b4f-4cad-9d61-89ffc4aabbc7 | gemcitabine 2 GM per 52.6 ML Injection | SY | 8 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20250203 |
| 22af3507-4b4f-4cad-9d61-89ffc4aabbc7 | gemcitabine 2 GM in 52.6 ML Injection | PSN | 8 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20250203 |
| 73ae04d8-38f9-4d3d-b0c2-71d22af1fc86 | gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection | SY | 7 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20240805 |
| 73ae04d8-38f9-4d3d-b0c2-71d22af1fc86 | 52.6 ML gemcitabine 38 MG/ML Injection | SCD | 7 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20240805 |
| 73ae04d8-38f9-4d3d-b0c2-71d22af1fc86 | gemcitabine 2 GM per 52.6 ML Injection | SY | 7 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20240805 |
| 73ae04d8-38f9-4d3d-b0c2-71d22af1fc86 | gemcitabine 2 GM in 52.6 ML Injection | PSN | 7 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20240805 |
| 06dd9d40-74fc-4409-93b1-a46be7126331 | gemcitabine 2 GM in 52.6 ML Injection | PSN | 6 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20241111 |
| 06dd9d40-74fc-4409-93b1-a46be7126331 | 52.6 ML gemcitabine 38 MG/ML Injection | SCD | 6 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20241111 |
| 06dd9d40-74fc-4409-93b1-a46be7126331 | gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection | SY | 6 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20241111 |
| 06dd9d40-74fc-4409-93b1-a46be7126331 | gemcitabine 2 GM per 52.6 ML Injection | SY | 6 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20241111 |
| d80176fe-3e8b-48be-87c2-9c603013b3fa | 52.6 ML gemcitabine 38 MG/ML Injection | SCD | 4 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20251024 |
| d80176fe-3e8b-48be-87c2-9c603013b3fa | gemcitabine 2 GM in 52.6 ML Injection | PSN | 4 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20251024 |
| d80176fe-3e8b-48be-87c2-9c603013b3fa | gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection | SY | 4 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20251024 |
| d80176fe-3e8b-48be-87c2-9c603013b3fa | gemcitabine 2 GM per 52.6 ML Injection | SY | 4 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20251024 |
| c0b1b715-9ff8-43ca-9e49-465f1f380084 | gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection | SY | 1 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20250723 |
| c0b1b715-9ff8-43ca-9e49-465f1f380084 | 52.6 ML gemcitabine 38 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20250723 |
| c0b1b715-9ff8-43ca-9e49-465f1f380084 | gemcitabine 2 GM in 52.6 ML Injection | PSN | 1 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20250723 |
| c0b1b715-9ff8-43ca-9e49-465f1f380084 | gemcitabine 2 GM per 52.6 ML Injection | SY | 1 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 1996 | 20250723 |
| 518b9c2e-fdbe-46de-9859-02314c220d58 | gemcitabine (as gemcitamine HCl) 2 GM per 52.6 ML Injection | SY | 1 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use. Initial U.S. Approval: 1996 | 20200104 |
| 518b9c2e-fdbe-46de-9859-02314c220d58 | gemcitabine 2 GM in 52.6 ML Injection | PSN | 1 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use. Initial U.S. Approval: 1996 | 20200104 |
| 518b9c2e-fdbe-46de-9859-02314c220d58 | gemcitabine 2 GM per 52.6 ML Injection | SY | 1 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use. Initial U.S. Approval: 1996 | 20200104 |
| 518b9c2e-fdbe-46de-9859-02314c220d58 | 52.6 ML gemcitabine 38 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use. Initial U.S. Approval: 1996 | 20200104 |